$AMOD
ALPHA MODUS HOLDINGS, INC. Stock $amod

$amod Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024099383 Filed on November 18, 2024

Income Statement

Concept	2024 Q3	2023 Q4	2023 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$52.63K	$1.121M	$525.4K
YoY Change	-89.98%	315.33%	88.73%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$73.13K	$1.115M	$1.411M
YoY Change	-94.82%	237.75%	329.89%
Operating Profit	-$73.13K		-$575.4K
YoY Change	-87.29%		75.29%
Interest Expense	-$151.2K	$157.2K	$391.5K
YoY Change	-138.62%	-96.09%	-86.78%
% of Operating Profit
Other Income/Expense, Net	-$151.2K	$0.00	$399.5K
YoY Change	-137.84%		-86.51%
Pretax Income	-$224.3K	-$957.4K	-$175.9K
YoY Change	27.55%	-125.94%	-106.68%
Income Tax	$11.77K	-$21.79K	$51.73K
% Of Pretax Income
Net Earnings	-$236.1K	-$935.6K	-$227.6K
YoY Change	3.73%	-128.35%	-109.52%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.04	-$0.03	-$0.03
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.81K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash & Equivalents	$11.81K
Short-Term Investments
Other Short-Term Assets	$83.64K	$420.1K	$392.3K
YoY Change	-78.68%	5.01%	-23.97%
Inventory
Prepaid Expenses	$83.64K	$105.6K	$86.17K
Receivables
Other Receivables	$145.0K	$195.0K
Total Short-Term Assets	$380.6K	$1.689M	$1.433M
YoY Change	-73.44%	213.49%	86.25%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$5.941M	$10.66M	$10.43M
YoY Change	-43.02%	-95.63%	-95.7%
Other Assets
YoY Change
Total Long-Term Assets	$5.941M	$10.66M	$10.43M
YoY Change	-43.02%	-95.63%	-95.7%
TOTAL ASSETS
Total Short-Term Assets	$380.6K	$1.689M	$1.433M
Total Long-Term Assets	$5.941M	$10.66M	$10.43M
Total Assets	$6.321M	$12.35M	$11.86M
YoY Change	-46.7%	-94.95%	-95.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$459.2K	$89.31K	$51.06K
YoY Change	799.42%	-30.68%	-68.03%
Accrued Expenses	$884.0K	$968.3K	$518.0K
YoY Change	70.66%	1319.47%	659.34%
Deferred Revenue
YoY Change
Short-Term Debt	$108.5K	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.655M	$5.260M	$4.626M
YoY Change	22.23%	485.09%	710.59%
LONG-TERM LIABILITIES
Long-Term Debt	$35.00K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$7.635M	$7.223M	$7.274M
YoY Change	4.97%	-40.31%	-48.3%
Total Long-Term Liabilities	$7.670M	$7.223M	$7.274M
YoY Change	5.45%	-40.31%	-48.3%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.655M	$5.260M	$4.626M
Total Long-Term Liabilities	$7.670M	$7.223M	$7.274M
Total Liabilities	$13.33M	$12.49M	$11.90M
YoY Change	12.02%	-4.92%	-18.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.21M	-$11.50M	-$11.26M
YoY Change	26.16%	-3.27%	-16.19%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$12.86M	-$10.99M	-$11.26M
YoY Change
Total Liabilities & Shareholders Equity	$6.321M	$12.35M	$11.86M
YoY Change	-46.7%	-94.95%	-95.12%

Cashflow Statement

Concept	2024 Q3	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$236.1K	-$935.6K	-$227.6K
YoY Change	3.73%	-128.35%	-109.52%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$220.2K	-$571.6K	-$1.407M
YoY Change	-84.34%	614.51%	1684.82%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$12.13K	-$20.00K	$19.80M
YoY Change	-99.94%		9518.38%
Cash From Investing Activities	$12.13K	-$20.00K	$19.80M
YoY Change	-99.94%		9518.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	137.3K	600.0K	-18.79M
YoY Change	-100.73%
NET CHANGE
Cash From Operating Activities	-220.2K	-571.6K	-1.407M
Cash From Investing Activities	12.13K	-20.00K	19.80M
Cash From Financing Activities	137.3K	600.0K	-18.79M
Net Change In Cash	-70.75K	8.390K	-396.0K
YoY Change	-82.14%	-110.49%	-411.74%
FREE CASH FLOW
Cash From Operating Activities	-$220.2K	-$571.6K	-$1.407M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	inaq	Gain On Forgiveness Of Deferred Underwriting Fee Payable GainOnForgivenessOfDeferredUnderwritingFeePayable		usd
CY2023Q3	inaq	Gain On Forgiveness Of Deferred Underwriting Fee Payable GainOnForgivenessOfDeferredUnderwritingFeePayable		usd
	inaq	Gain On Forgiveness Of Deferred Underwriting Fee Payable GainOnForgivenessOfDeferredUnderwritingFeePayable		usd
	dei	Entity Registrant Name EntityRegistrantName	Insight Acquisition Corp. /DE
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q3	inaq	Change In Initial Value Of Forward Purchase Agreement Liability ChangeInInitialValueOfForwardPurchaseAgreementLiability		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity File Number EntityFileNumber	001-40775
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-3386030
	dei	Entity Address Address Line1 EntityAddressAddressLine1	333 East 91st Street
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address City Or Town EntityAddressCityOrTown	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10128
	dei	City Area Code CityAreaCode	(609)
	dei	Local Phone Number LocalPhoneNumber	751-3193
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2024Q3	us-gaap	Cash Cash	11810	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	314482	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	83642	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	105568	usd
CY2024Q3	inaq	Due From Sponsor Current DueFromSponsorCurrent	140139	usd
CY2023Q4	inaq	Due From Sponsor Current DueFromSponsorCurrent	1074015	usd
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	145028	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	195000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	380619	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1689065	usd
CY2024Q3	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	5940746	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	10664690	usd
CY2024Q3	us-gaap	Assets Assets	6321365	usd
CY2023Q4	us-gaap	Assets Assets	12353755	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	459201	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	89311	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	883998	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	968309	usd
CY2024Q3	inaq	Due To Investor Netof Debt Discount DueToInvestorNetofDebtDiscount	975000	usd
CY2023Q4	inaq	Due To Investor Netof Debt Discount DueToInvestorNetofDebtDiscount	320755	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	628758	usd
CY2024Q3	us-gaap	Loans Payable Current LoansPayableCurrent	108466	usd
CY2024Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	48649	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	100036	usd
CY2024Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2402516	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2348302	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5654830	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5260471	usd
CY2024Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5161	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	9935	usd
CY2024Q3	inaq	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	6600000	usd
CY2023Q4	inaq	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	6600000	usd
CY2024Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1035000	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	623090	usd
CY2024Q3	us-gaap	Liabilities Liabilities	13329991	usd
CY2023Q4	us-gaap	Liabilities Liabilities	12493496	usd
CY2024Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	5850330	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	10847403	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1349771	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	509211	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14209327	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11496955	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-12858956	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-10987144	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6321365	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12353755	usd
CY2024Q3	inaq	General And Administrative Expenses Related Party GeneralAndAdministrativeExpensesRelatedParty	52630	usd
CY2023Q3	inaq	General And Administrative Expenses Related Party GeneralAndAdministrativeExpensesRelatedParty	525375	usd
	inaq	General And Administrative Expenses Related Party GeneralAndAdministrativeExpensesRelatedParty	902076	usd
	inaq	General And Administrative Expenses Related Party GeneralAndAdministrativeExpensesRelatedParty	1597947	usd
CY2024Q3	us-gaap	Franchisor Costs FranchisorCosts	20500	usd
CY2023Q3	us-gaap	Franchisor Costs FranchisorCosts	50000	usd
	us-gaap	Franchisor Costs FranchisorCosts	76700	usd
	us-gaap	Franchisor Costs FranchisorCosts	150000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-73130	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-575375	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-978776	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1747947	usd
CY2024Q3	inaq	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	227700	usd
CY2023Q3	inaq	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	-7245	usd
	inaq	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	411910	usd
	inaq	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	588915	usd
CY2023Q3	inaq	Change In Initial Value Of Forward Purchase Agreement Liability ChangeInInitialValueOfForwardPurchaseAgreementLiability	8035	usd
	inaq	Change In Initial Value Of Forward Purchase Agreement Liability ChangeInInitialValueOfForwardPurchaseAgreementLiability	86369	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1109250	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	456449	usd
CY2024Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	76525	usd
CY2023Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	384239	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	357115	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	2898987	usd
	inaq	Gain On Forgiveness Of Deferred Underwriting Fee Payable GainOnForgivenessOfDeferredUnderwritingFeePayable	273110	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-151175	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	399519	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1620494	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2669551	usd
CY2024Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-224305	usd
CY2023Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-175856	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2599270	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	921604	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11766	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51725	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58888	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	637175	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-236071	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-227581	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2658158	usd
	us-gaap	Net Income Loss NetIncomeLoss	284429	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-10987144	usd
CY2024Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	168352	usd
CY2024Q1	inaq	Adjustments To Additional Paid In Capital Fair Value Of Subscription Shares In Connection With Subscription Agreement AdjustmentsToAdditionalPaidInCapitalFairValueOfSubscriptionSharesInConnectionWithSubscriptionAgreement	177204	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-633846	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-11612138	usd
CY2024Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	202137	usd
CY2024Q2	inaq	Stock Issued During Period Value Excise Tax Payable StockIssuedDuringPeriodValueExciseTaxPayable	-54214	usd
CY2024Q2	inaq	Adjustments To Additional Paid In Capital Fee Waiver Agreement AdjustmentsToAdditionalPaidInCapitalFeeWaiverAgreement	1436250	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	327000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1788241	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-12547480	usd
CY2024Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	75405	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-236071	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-12858956	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11884732	usd
CY2023Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-3628151	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	100000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	-86369	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	895469	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-7347481	usd
CY2023Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	253965	usd
CY2023Q2	inaq	Stock Issued During Period Value Excise Tax Payable StockIssuedDuringPeriodValueExciseTaxPayable	-2156214	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-383459	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-10141119	usd
CY2023Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	701466	usd
CY2023Q3	inaq	Stock Issued During Period Value Excise Tax Payable StockIssuedDuringPeriodValueExciseTaxPayable	-192088	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-227581	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-11262254	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2658158	usd
	us-gaap	Net Income Loss NetIncomeLoss	284429	usd
	inaq	Change In Initial Valueof Derivative Liabilities ChangeInInitialValueofDerivativeLiabilities	411910	usd
	inaq	Change In Initial Valueof Derivative Liabilities ChangeInInitialValueofDerivativeLiabilities	588915	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	456449	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	357115	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2898986	usd
	inaq	Gain On Forgiveness Of Deferred Underwriting Fee Payable GainOnForgivenessOfDeferredUnderwritingFeePayable	273110	usd
	inaq	Gain Loss Change In Fair Value Of Forward Purchase Agreement Liability GainLossChangeInFairValueOfForwardPurchaseAgreementLiability	86369	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1109250	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4774	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-156593	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-21926	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-281046	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	369890	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-77780	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-84311	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	449786	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-58000	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	225000	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-49972	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	891000	usd
	inaq	Increase Decrease Due From Sponsor IncreaseDecreaseDueFromSponsor	225000	usd
	inaq	Increase Decreasein Due To Investors IncreaseDecreaseinDueToInvestors	25000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-51387	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	203768	usd
	inaq	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	-8159	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-994348	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2342735	usd
	inaq	Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes	236505	usd
	inaq	Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes	2457248	usd
	inaq	Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption ProceedsFromCashWithdrawnFromTrustAccountInConnectionWithRedemption	6071725	usd
	inaq	Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption ProceedsFromCashWithdrawnFromTrustAccountInConnectionWithRedemption	234830236	usd
	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	1227171	usd
	inaq	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	500000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5081059	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	236787484	usd
	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	100000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	420000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	30000	usd
	inaq	Proceeds Pursuant To Subscription Agreement ProceedsPursuantToSubscriptionAgreement	350000	usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	1158876	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	108466	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	35000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	650402	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5421323	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	234830236	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4389383	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-234310236	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-302672	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	134513	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	314482	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	171583	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11810	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	306096	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11810	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	306096	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11810	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	306096	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	236505	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1447889	usd
	inaq	Forgiveness Of Deferred Underwriting Fee Payable ForgivenessOfDeferredUnderwritingFeePayable	5126890	usd
	inaq	Fair Value Of Subscription Shares FairValueOfSubscriptionShares	177204	usd
	inaq	Initial Value Of The Forward Purchase Agreement Liability InitialValueOfTheForwardPurchaseAgreementLiability	54214	usd
	inaq	Initial Value Of The Forward Purchase Agreement Liability InitialValueOfTheForwardPurchaseAgreementLiability	2348302	usd
	inaq	Increase In Due To Investor IncreaseInDueToInvestor	150000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 1 - Description of Organization and Business Operations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.1pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Insight Acquisition Corp. (the “Company”) was incorporated in Delaware on April 20, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has one subsidiary, IAC Merger Sub Inc., a Florida corporation (“Merger Sub”), a direct wholly owned subsidiary of the Company incorporated on October 10, 2023. As of September 30, 2024 the subsidiary had no activity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2024, the Company had not commenced any operations. All activity for the period from April 20, 2021 (inception) through September 30, 2024 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below and subsequent to the Initial Public Offering, the search for a business combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. On October 29, 2024, the Company held a Special Meeting of stockholders. At the Special Meeting, the Company’s stockholders approved the Business Combination Agreement, dated as of October 13, 2023, as amended by the First Amendment to the Business Combination Agreement, dated as of June 21, 2024. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s sponsor is Insight Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on September 1, 2021. On September 7, 2021, the Company consummated its Initial Public Offering of 24,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), generating gross proceeds of $240.0 million, and incurring offering costs of approximately $17.5 million, of which approximately $12.0 million and approximately $668,000 were for deferred underwriting commissions (see Note 5) and offering costs allocated to derivate warrant liabilities, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 7,500,000 and 1,200,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), to the Sponsor and Cantor Fitzgerald & Co. (“Cantor”) and Odeon Capital Group, LLC (“Odeon”), respectively, for an aggregate of 8,700,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant, generating proceeds of $8.7 million (see Note 4).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon the closing of the Initial Public Offering and the Private Placement, $241.2 million ($10.05 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and of the Private Placement Warrants in the Private Placement were placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes and excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will provide the holders of the Company’s outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholders meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, in its sole discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially at $10.05 per Public Share plus pro rata interest earned in Trust Account). The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares were recorded at a redemption value and classified as temporary equity in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the holders of 65% of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the Initial Stockholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 3) and any Public Shares purchased during or after the Initial Public Offering, and the Anchor Investors (as defined below in Note 3) agreed to vote any Founder Shares held by them in favor of a Business Combination. In addition, the Initial Stockholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. The Company’s Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Sponsor and the Company’s officers and any other holders of the Founder Shares immediately prior to the Initial Public Offering (the “Initial Stockholders”) agreed not to propose an amendment to the Certificate of Incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Anchor Investors are not entitled to (i) redemption rights with respect to any Founder Shares held by them in connection with the completion of the initial Business Combination, (ii) redemption rights with respect to any Founder Shares held by them in connection with a stockholder vote to amend the Certificate of Incorporation in a manner that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (iii) rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the Company is unable to complete a Business Combination by June 7, 2024, which may be extended only by the vote of the stockholders to approve an amendment to the amended and restated certificate of incorporation (the “Combination Period”) the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject, in each case, to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 6, 2023 the Company held a special meeting (the “Special Meeting”) of stockholders. At the Special Meeting, the Company’s stockholders were asked to vote on the following items: (i) a proposal to amend the Charter to extend the date by which the Company has to consummate a business combination for an additional one month, from March 7, 2023 to April 7, 2023 and thereafter, at the discretion of the board of directors of the Company and without a vote of the stockholders, up to five (5) times for an additional one month each time, for a total of up to five additional months to September 7, 2023 (the “First Charter Amendment Proposal”), (ii) a proposal to amend the Company’s Charter to eliminate from the Charter the limitation that the Company may not redeem public shares to the extent that such redemption would result in the Company having net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) of less than $5,000,001 (the “Redemption Limitation”) in order to allow the Company to redeem public shares irrespective of whether such redemption would exceed the Redemption Limitation (the “Second Charter Amendment Proposal”), (iii) a proposal to amend the Charter to provide for the right of a holder of Class B common stock of the Company, par value $0.0001 per share (“Class B Common Stock”) to convert such shares into shares of Class A common stock of the Company, par value $0.0001 per share (“Class A Common Stock”) on a one-for-one basis prior to the closing of a business combination at the election of the holder (the “Third Charter Amendment Proposal” and together with the First Charter Amendment Proposal and the Second Charter Amendment Proposal, the “Charter Amendment Proposals”) and (iv) a proposal to direct the chairman of the Special Meeting to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve each of the Charter Amendment Proposals. In connection with the Extension, the holders of 21,151,393 Class A common shares, representing approximately 88.1% of the Company’s issued and outstanding Class A common shares, elected to redeem their shares. Following such redemptions, approximately $28,744,831 remained in the trust account and 2,848,607 shares of Class A Common Stock remained issued and outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.1pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 28, 2023, the board of directors of the Company approved a one-month extension of the date by which the Company has to consummate a business combination to May 7, 2023 and authorized management to deposit $80,000 into the Trust Account for such extension. Accordingly, management deposited $80,000 into the Trust Account and the date by which the Company has to consummate a business combination has been extended to May 7, 2023. On May 2, 2023, the board of directors of the Company approved an additional one-month extension to June 7, 2023 and deposited an additional $80,000 into the Trust Account.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 29, 2023, the Company entered into a forward share purchase agreement (the “Forward Share Purchase Agreement”) with Avila, Meteora Special Opportunity Fund I, LP, Meteora Capital Partners, LP and Meteora Select Trading Opportunities Master, LP (collectively, “Seller”) for an OTC Equity Prepaid Forward Transaction (the “Forward Purchase Transaction”). Pursuant to the terms of the Forward Purchase Agreement, Seller intends but is not obligated to purchase the Company’s Class A Common Stock from holders (other than the Company or its affiliates) who have elected to redeem such shares in connection with the Proposed Transactions. Purchases by Seller will be made through brokers in the open market after the redemption deadline in connection with the Proposed Transactions at a price no higher than the redemption price to be paid by the Company in connection with the Proposed Transactions (the “Initial Price”). The Shares purchased by the Seller, other than the Share Consideration Shares are referred to herein as the “Recycled Shares.” The Seller also may sell 2,376,000 shares of the Company Class A Common Stock purchased in the Company’s initial public offering (“IPO Shares”) in the Forward Purchase Transaction, up to a maximum of 2,500,000 shares of Class A Common Stock (including any Recycled Shares).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 3, 2023, the Company entered into a Business Combination Agreement (“Avila BCA”) with Avila Energy Corporation, an Alberta corporation (“Avila”), pursuant to which the Company will acquire Avila for consideration of shares of the Company following its redomicile into the Province of Alberta. The business combination agreement and related executed agreements included supporting agreements and a forward share purchase agreement are more fully described and filed with the Company’s Current Report on Form 8-K filed with the SEC on April 4, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 18, 2023, the Company received a notification from the New York Stock Exchange (“NYSE”) that it was in violation of NYSE requirements as it had failed to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”) and that if the Form 10-K is not filed with the SEC by 2:30 p.m. Eastern Time on April 21, 2023, the NYSE would post the Company to the NYSE’s late filers list on the Profile, Data and News pages with respect to each of the Company’s securities (the “LF Designation”). Effective April 19, 2023, the Company filed the Form 10-K and that same day the Company received additional correspondence from the NYSE acknowledging that the filing had been made and cancelling its prior correspondence and stating that the LF Designation would not be posted on the Profile, Data and News pages with respect to each of the Company’s securities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 27, 2023, the Company issued a press release reporting that the Company will transfer the listing of its securities to The Nasdaq Stock Market (“Nasdaq”). In the press release, the Company stated that its securities will commence trading on Nasdaq upon the market open on Tuesday, May 2, 2023. The Company’s Class A common stock will continue trading under the ticker symbol “INAQ” on the Nasdaq Global Market and the Company’s units and warrants will continue trading under the ticker symbols “INAQU” and “INAQW,” respectively, on the Nasdaq Capital Market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 24, 2023, the Company received a notification from the Nasdaq that it was not in compliance with Nasdaq Listing Rule 5250I(1) as it had failed to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Form 10-Q”). Under the Nasdaq Listing Rules, the Company now has 60 calendar days to submit a plan to regain compliance and if the plan is accepted, Nasdaq may grant an exception of up to 180 calendar days from the Form 10-Q’s due date, or until November 20, 2023, to regain compliance. The Company subsequently filed the Form 10-Q for the quarter ended March 31, 2023 on June 2, 2023, regaining compliance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 10, 2023, the Company and Avila entered into a Letter Agreement providing for the mutual termination of the Avila BCA. The Letter Agreement provides for the mutual release of claims against the other party and also provides that Avila will pay to the Company $300,000 in partial reimbursement of expenses incurred by the Company in connection with the Avila BCA (the “Avila Payment”). The Avila Payment is due and payable as follows: 1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 17, 2023, the Company issued an unsecured promissory note in the aggregate principal amount of $480,000 (the “Note”) to the Sponsor, in exchange for the Sponsor advancing $480,000 to the Company to fund six one-month extensions of the amount of time the Company has to complete its initial business combination, from March 7, 2023 to September 7, 2023. The Note does not bear interest and matures upon the closing of an initial business combination by the Company. In addition, at the option of the holder, the Note may be paid by the Company through the issuance of private placement warrants of the Company at a price of $1.00 per unit. The loan will be forgiven, except to the extent of any funds held outside of the Company’s trust account, by the Sponsor, if Company is unable to consummate an initial business combination. On November 6, 2023, the Company and the Sponsor entered into a written agreement (the “Rescission Agreement”) to rescind and nullify that certain promissory note in the principal amount of $480,000 and executed on August 17, 2023 (the “Note”) pursuant to which the Company agreed to pay the Sponsor the principal amount of $480,000 subject to the terms and conditions of the Note. Upon execution and delivery of the Rescission Agreement, the Note, in its entirety, is hereby irrevocably rescinded, abrogated, cancelled and rendered null and void ab initio and of no force or effect whatsoever, and the positions among the Company and the Sponsor shall be restored to what would have existed had they not entered into the Note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As approved by its stockholders at the annual meeting of stockholders held on September 6, 2023 (the “Annual Meeting”), the Company filed a Second Amendment (the “Second Amendment”) to its Amended and Restated Certificate of Incorporation (the “Charter”) with the Delaware Secretary of State on September 6, 2023 to modify the terms and extend Combination Period by which the Company has to consummate an initial business combination (the “Business Combination”) from September 7, 2023 to June 7, 2024, provided that the Company deposits the lesser of $20,000 and $0.02 for each outstanding share of common stock sold in the Company’s initial public offering into the Trust Account, as defined in the Charter for each one-month extension. In connection with the stockholder’s vote at the Annual Meeting, 1,847,662 shares were tendered for redemption in exchange for a total redemption payment of $19,208,848. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 7, 2023, October 7, 2023, November 7, 2023, December 15, 2023, January 5, 2024, February 2, 2024, February 7, 2024, March 20, 2024 and May 6, 2024, the Company deposited $20,000 into the Trust Account on each date, to extend the Business Combination Period from September 7, 2023 to June 7, 2024. On June 6, 2024, July 31, 2024, August 21, 2024, September 11, 2024, October 7, 2024, and November 15, 2024, the Company deposited $10,382 or $0.02 for each outstanding share of common stock sold in the Company’s initial public offering into the Trust Account on each date to extend the Business Combination Period from June 7, 2024 to November 7, 2024. The Company will deposit an additional amount of $10,382 or $0.02 for each outstanding share of common stock sold in the Company’s initial public offering into the Trust Account on or before the closing date of the Business Combination to extend the Business Combination Period to December 7, 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective as of October 13, 2023, the Company, IAC Merger Sub Inc., a Florida corporation (“Merger Sub”) and Alpha Modus, Corp., a Florida corporation (“Alpha Modus”), entered into a business combination agreement and plan of merger (the “AM BCA”) pursuant to which Merger Sub will merge with and into Alpha Modus with Alpha Modus as the surviving corporation and becoming a wholly owned subsidiary of the Company. The Board of Directors of the Company (the “Board”) has unanimously approved and declared advisable the AM BCA, the Merger and the other transactions contemplated thereby (the “Proposed Transactions”). A copy of the AM BCA is filed as Exhibit 2.1 in the Current Report on Form 8-K, dated October 17, 2023. In connection with entering into the AM BCA, in October 2023, the Company formed IAC Merger Sub Inc., a Florida corporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 28, 2023, the Company filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form S-4 (the “Registration Statement”) in connection with the proposed business combination with Alpha Modus, Corp. based in Metro-Charlotte, NC (the “Business Combination”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 21, 2024, Jeff Gary, in connection with his departure as an officer and director of the Company, waived and forfeited any monies he was owed under the Sponsor Payment Agreement and/or Management Payment Agreement. On June 21, 2024, the Company, Sponsor and Michael Singer entered into a fee waiver agreement (the “Waiver Agreement”) pursuant to which the Sponsor and Michael Signer agreed that in exchange for Michael Singer’s receipt of 125,000 shares of the Company’s Class A common stock to be delivered at the closing of the proposed business combination between the Company and Alpha Modus Corp., the Sponsor and Michael Singer agreed to waive all amounts due to them now and in the future under the Sponsor Payment Agreement and Management Payment Agreement on the terms and conditions set forth in the Waiver Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 5, 2024, the Company held a special meeting of stockholders (the “Special Meeting”). At the Special Meeting the Company’s stockholders approved the filing of a Third Amendment (the “Third Amendment”) to its Amended and Restated Certificate of Incorporation (the “Charter”) with the Delaware Secretary of State to modify the terms and extend time by which the Company has to consummate an initial business combination (the “Business Combination”) from June 7, 2024 to December 7, 2024, provided that the Company deposits the lesser of $20,000 and $0.02 for each outstanding share of common stock sold in the Company’s initial public offering into the Trust Account, as defined in the Charter for each one-month extension. In connection with the stockholder’s vote at the Special Meeting and the planned filing of the Third Amendment, 481,865 shares of the Company’s Class A Common Stock, $0.0001 par value per share, were tendered for redemption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 27, 2024, the Company received the Notice from the Nasdaq Stock Market LLC (“Nasdaq”), stating that the Company did not comply with Nasdaq Interpretive Material IM-5101-2, and that its securities are now subject to delisting. The Company’s registration statement filed in connection with the Company’s IPO became effective on September 1, 2021. Pursuant to IM-5101-2, the Company, a special purpose acquisition company, must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. Since the Company failed to complete its initial business combination by September 1, 2024, the Company did not comply with IM5101-2, and its securities are now subject to delisting. Unless the Company requests an appeal of this determination by October 4, 2024, trading of the Company’s securities will be suspended at the opening of business on October 8, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing and registration on The Nasdaq Stock Market. The Company appealed the determination contained in the Notice and a hearing on the appeal was scheduled for November 14, 2024 (the “Hearing”). The Hearing was held on November 14, 2024 and the Company requested an extension until December 31, 2024 to complete the Business Combination. The Company is waiting for the decision on its appeal.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Initial Stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.05. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.05 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.05 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.1pt; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks and Uncertainties</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these unaudited condensed consolidated financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any share redemption or other share repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the second quarter of 2024, the Internal Revenue Service issued final regulations with respect to the timing and payment of the excise tax. These regulations provided that the filing and payment deadline for any liability incurred during the period from January 1, 2023 to December 31, 2023 would be October 31, 2024. The Company is currently evaluating its options with respect to this obligation. Any amount of such excise tax not paid in full, will be subject to additional interest and penalties which are currently estimated at 10% interest per annum and a 5% underpayment penalty per month or portion of a month up to 25% of the total liability for any amount that is unpaid from November 1, 2024 until paid in full.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company held a meeting on March 6, 2023 where the stockholders voted to approve a proposal to amend the Company’s amended and restated certificate of incorporation to extend the Combination Period, from March 7, 2023, monthly for up to six additional months at the election of the Company, ultimately until as late as September 7, 2023 (the “Extension”, and such extension date the “Extended Date”). In connection with the March 6, 2023 meeting, 21,151,393 shares of the Company’s common stock were redeemed with a total redemption payment of $215,621,387.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company held its annual meeting on September 6, 2023 where the stockholders voted to approve a proposal to amend the Company’s amended and restated certificate of incorporation to extend the Combination Period, from September 7, 2023 to June 7, 2024, provided that the Company deposits the lesser of $20,000 and $0.02 for each outstanding share of common stock sold in the Company’s initial public offering into the Trust Account, as defined in the Charter for each one-month extension. In connection with the stockholder’s vote at the Annual Meeting, 1,847,662 shares were tendered for redemption in exchange for a total redemption payment of $19,208,848.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company held a special meeting on June 5, 2024 where the stockholders voted to approve a proposal to amend the Company’s amended and restated certificate of incorporation to extend the Combination Period, from June 7, 2024 to December 7, 2024, provided that the Company deposits the lesser of $20,000 and $0.02 for each outstanding share of common stock sold in the Company’s initial public offering into the Trust Account, as defined in the Charter for each one-month extension. In connection with the stockholder’s vote at the Special Meeting, 481,865 shares were tendered for redemption in exchange for a total redemption payment of $5,421,323.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result, the Company booked a liability of $2,348,302 for the excise tax based on 1% of shares redeemed during the year ended December 31, 2023 and $54,214 for the excise tax based on 1% of shares redeemed during the nine months ended September 30, 2024. For interim periods, an entity is not required to estimate future stock repurchases and stock issuances to measure its excise tax obligation. Rather, an entity can generally record the obligation on an as-incurred basis. In other words, the excise tax obligation recognized at the end of a quarterly financial reporting period is calculated as if the end of the quarterly period was the end of the annual period for which the excise tax obligation is payable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the AM BCA, (i) in the event the business combination contemplated by the AM BCA occurs, then the surviving company shall pay the Company’s excise tax liability; (ii) if Alpha Modus does not obtain its shareholders approval of the business combination, or Alpha Modus breaches the AM BCA, then Alpha Modus will be responsible to pay the Company’s excise tax liability; and (iii) if an Alpha Modus material adverse effect occurs and the business combination does not close, or if Alpha Modus fails to close the business combination for any reason other than a material breach by the Company, then Alpha Modus will be responsible to pay the Company’s excise tax liability. In all other circumstances the Company will be responsible to pay the Company’s excise tax liability. The Company will not use any of the funds held in the Trust Account and any additional amounts deposited into the Trust Account, as well as any interest earned thereon, to pay for the Company’s excise tax liability. In addition, because the excise tax would be payable by the Company and not by the redeeming holders, the mechanics of any required payment of the excise tax by the Company have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2023, the Israel-Hamas war commenced. As a result of the war, instability in the Middle East and various other regions of the world may occur and effect the world economy. Various nations, including the United States, as a reaction to the Israel-Hamas war have begun taking actions that may further affect the world economy. Such effects on the world economy are not determinable as of the date of these unaudited condensed consolidated financial statements. The specific impact on the Company’s financial condition, results of operations and cash flows is also not determinable as of the date of these unaudited condensed consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Emerging Growth Company</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.1pt; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Liquidity and Going Concern</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.1pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2024, the Company had $11,810 in its operating bank account available to pay operating expenses and working capital deficit of $5,274,211.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover for certain offering costs on behalf of the Company in exchange for issuance of the Founder Shares (as defined in Note 3), and the loan from the Sponsor of approximately $163,000 under the Note (as defined in Note 4). The Company repaid $157,000 of Note balance on September 7, 2021 and repaid the remaining balance of approximately $6,000 in full on September 13, 2021, at which time the Note was terminated. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). As of September 30, 2024 and December 31, 2023, there were no amounts outstanding under any Working Capital Loans.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 17, 2023, the Company issued an unsecured promissory note in the aggregate principal amount of $480,000 (the “Note”) to the Sponsor, in exchange for the Sponsor advancing $480,000 to the Company to fund six one-month extensions of the amount of time the Company has to complete its initial business combination, from March 7, 2023 to September 7, 2023. The Note does not bear interest and matures upon the closing of an initial business combination by the Company. In addition, at the option of the holder, the Note may be paid by the Company through the issuance of private placement warrants of the Company at a price of $1.00 per unit. The loan will be forgiven, except to the extent of any funds held outside of the Company’s trust account, by the Sponsor, if Company is unable to consummate an initial business combination. On November 6, 2023, the Company and the Sponsor entered into a written agreement (the “Rescission Agreement”) to rescind and nullify that certain promissory note in the principal amount of $480,000 and executed on August 17, 2023 (the “Note”) pursuant to which the Company agreed to pay the Sponsor the principal amount of $480,000 subject to the terms and conditions of the Note. Upon execution and delivery of the Rescission Agreement, the Note, in its entirety, is hereby irrevocably rescinded, abrogated, cancelled and rendered null and void ab initio and of no force or effect whatsoever, and the positions among the Company and the Sponsor shall be restored to what would have existed had they not entered into the Note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 30, 2023, the Company, Sponsor and Polar Multi-Strategy Master Fund (“Polar”), an investor, entered into an agreement (the “Subscription Agreement”) in which Polar has agreed to fund the Sponsor up to $1,000,000, pursuant to written draw down requests (a “Capital Call”), and the Sponsor will in turn loan such funds to the Company, to cover the Company’s working capital expenses (each a “Sponsor Loan”). On May 15, 2024, the Company, Sponsor and Polar entered into Amendment No. 1 to the Subscription Agreement (the Amendment”) pursuant to which Polar’s aggregate advance under the Subscription Agreement was reduced from $1,000,000 to $975,000 (see Note 6). For the nine months ended September 30, 2024, Polar funded Sponsor additional $375,000 under the Subscription Agreement and the Sponsor loaned the Company $375,000 from Polar. For the year ended December 31, 2023, Polar funded Sponsor $600,000 under the Subscription Agreement and the Sponsor loaned the Company $600,000 from Polar. As of September 30, 2024 and December 31, 2023, there were outstanding amounts of $975,000 and $600,000 due to Polar, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 25, 2024, the Company issued an unsecured promissory note in the aggregate principal amount of $35,000 (the “Note”) to a related party, the Note being entered into in consideration of two transfers made by Jeffrey J. Gary to the Maker on April 18, 2024 for $25,000 and on May 22, 2024 for $10,000. The Note does not bear interest and matures upon the closing of an initial business combination by the Company. The principal balance may be repaid at any time. The principal balance shall be payable by the Company either: (i) in cash, or (ii) at the Payee’s election in writing, by issuance of Maker’s private placement warrants (the “Private Warrants”), at a price of $1.00 per Private Warrant. Each Private Warrant entitles the holder to purchase one share of Class A common stock at $11.50 per share. As of September 30, 2024, there was $35,000 outstanding amount under this Note included on the condensed consolidated balance sheets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until December 7, 2024 (extended monthly through extension payments), to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. The Company will need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management intends to complete a Business Combination by close of business on December 7, 2024. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 7, 2024.</p>
	inaq	Condition For Future Business Combination Number Of Businesses Minimum ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum	1	pure
	inaq	Investments Maximum Maturity Term InvestmentsMaximumMaturityTerm	P185D
CY2024Q3	inaq	Percentage Of Fair Market Value Of Target Business To Asset Held In Trust Account PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount	0.80	pure
CY2024Q3	inaq	Percentage Of Shares Voted PercentageOfSharesVoted	0.65	pure
CY2024Q3	us-gaap	Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities	100000	usd
	inaq	Condition For Future Business Combination Threshold Net Tangible Assets ConditionForFutureBusinessCombinationThresholdNetTangibleAssets	5000001	usd
	inaq	Avila Payment Description AvilaPaymentDescription	1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024.
CY2023Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	1847662	shares
CY2023Q3	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	19208848	usd
CY2024Q2	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	481865	shares
	inaq	Interest Per Annum InterestPerAnnum	0.10	pure
	inaq	Underpayment Penalty Per Month UnderpaymentPenaltyPerMonth	0.05	pure
	inaq	Total Liability Unpaid Percentage TotalLiabilityUnpaidPercentage	0.25	pure
CY2023Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	1847662	shares
CY2023Q3	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	19208848	usd
CY2023	inaq	Excise Tax Liability ExciseTaxLiability	2348302	usd
CY2023	inaq	Percentage Of Excise Tax Shares Redeemed During The Period PercentageOfExciseTaxSharesRedeemedDuringThePeriod	0.01	pure
	inaq	Excise Tax Liability ExciseTaxLiability	54214	usd
	inaq	Percentage Of Excise Tax Shares Redeemed During The Period PercentageOfExciseTaxSharesRedeemedDuringThePeriod	0.01	pure
CY2024Q3	inaq	Working Capital Deficit WorkingCapitalDeficit	5274211	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	usd
	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	163000	usd
CY2021Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	157000	usd
CY2021Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	6000	usd
CY2023Q4	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	480000	usd
	inaq	Sponsor Loan SponsorLoan	375000	usd
CY2023	inaq	Sponsor Loan SponsorLoan	600000	usd
CY2024Q3	inaq	Outstanding Loan Due OutstandingLoanDue	975000	usd
CY2023Q4	inaq	Outstanding Loan Due OutstandingLoanDue	600000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	314482	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</p>
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. One of the more significant accounting estimates included in these unaudited condensed consolidated financial statements is the determination of the fair value of the warrant liabilities. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2024Q3	us-gaap	Other Loans Payable OtherLoansPayable	800000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	568503	usd
CY2024Q3	us-gaap	Other Liabilities OtherLiabilities	0	usd
CY2024Q3	us-gaap	Loans Payable LoansPayable	175000	usd
	inaq	Allocated As Fair Value AllocatedAsFairValue	0	usd
CY2024Q3	inaq	Subscription Receivable SubscriptionReceivable	975000	usd
CY2024Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5161	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	9935	usd
CY2024Q3	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	12000	usd
CY2023Q3	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	52000	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	59000	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	637000	usd
CY2024Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
	inaq	Units Issued During Period Shares New Issues UnitsIssuedDuringPeriodSharesNewIssues	24000000	shares
	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	the Company effected a 1:1.1162791 stock split of Class B common stock
CY2023Q3	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	30000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	90000	usd
CY2024Q2	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	132500	usd
CY2024Q2	inaq	Service Fees ServiceFees	7500	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	24500	usd
CY2024Q1	inaq	Aggregate Fair Value Of Business Combination Shares AggregateFairValueOfBusinessCombinationShares	125000	shares
CY2024Q1	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	1436250	usd
CY2024Q1	inaq	Aggregate Fair Value Per Share AggregateFairValuePerShare	11.49
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	480000	usd
CY2024Q3	inaq	Sponsor Advance SponsorAdvance	485000	usd
CY2023Q4	inaq	Operating Bank Account OperatingBankAccount	616000	usd
CY2023Q4	inaq	Operating Bank Account OperatingBankAccount	616000	usd
CY2023Q4	inaq	Operating Bank Account OperatingBankAccount	616000	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-49972	usd
	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	2497248	usd
	us-gaap	Debt Instrument Repaid Principal DebtInstrumentRepaidPrincipal	1447889	usd
	inaq	Withdrawn Amount From Trust Account For Tax Purposes WithdrawnAmountFromTrustAccountForTaxPurposes	1049359	usd
CY2024Q1	inaq	Withdrawn Amount From Trust Account Erroneously WithdrawnAmountFromTrustAccountErroneously	1049359	usd
CY2024Q1	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	24656	usd
CY2024Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	1090000	usd
CY2023Q1	inaq	Waiver Of Underwriting Commissions WaiverOfUnderwritingCommissions	5400000	usd
CY2023Q1	inaq	Deferred Underwriting Commissions DeferredUnderwritingCommissions	8400000	usd
CY2023Q1	inaq	Gain Loss On Forgiveness Of Deferred Underwriting Fees Payable GainLossOnForgivenessOfDeferredUnderwritingFeesPayable	273110	usd
CY2023Q1	inaq	Reminder Of Deferred Underwriting Commissions ReminderOfDeferredUnderwritingCommissions	3000000	usd
CY2024Q3	inaq	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	6600000	usd
CY2023Q4	inaq	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	6600000	usd
CY2023Q1	inaq	Deferred Underwriting Discount DeferredUnderwritingDiscount	1000000	usd
CY2024Q2	inaq	Deferred Underwriting Discount DeferredUnderwritingDiscount	6600000	usd
CY2023Q3	inaq	Reimbursement Of Expenses ReimbursementOfExpenses	300000	usd
CY2023Q3	inaq	Net Proceeds NetProceeds	300000	usd
CY2023Q3	us-gaap	Other Commitment OtherCommitment	3000000	usd
CY2023Q4	us-gaap	Other Commitment OtherCommitment	50000	usd
CY2024Q1	us-gaap	Other Commitment OtherCommitment	100000	usd
CY2024Q2	us-gaap	Other Commitment OtherCommitment	150000	usd
CY2024Q2	inaq	Earout Shares EaroutShares	2200000	shares
CY2024Q4	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	426135	usd
	us-gaap	Payments For Fees PaymentsForFees	375000	usd
	inaq	Sponsor Loaned SponsorLoaned	375000	usd
CY2023	us-gaap	Payments For Fees PaymentsForFees	600000	usd
CY2023	inaq	Sponsor Loaned SponsorLoaned	600000	usd
CY2024Q3	us-gaap	Capital Units Outstanding CapitalUnitsOutstanding	10	shares
	inaq	Reasonable Attorneys Fees ReasonableAttorneysFees	5000	usd
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
CY2024Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
	inaq	Share Redemption Trigger Price ShareRedemptionTriggerPrice	18
CY2024Q3	inaq	Class Of Warrant Or Right Redemption Price Of Warrants Or Rights ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights	0.01
	inaq	Class Of Warrant Or Right Redemption Of Warrants Or Rights ClassOfWarrantOrRightRedemptionOfWarrantsOrRights	P30D
CY2024Q3	us-gaap	Other Additional Capital OtherAdditionalCapital	5000000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	20000000	usd
	inaq	Percentage Of Purchase Price Accrue Interest PercentageOfPurchasePriceAccrueInterest	0.10	pure
	inaq	Number Of Trading Days NumberOfTradingDays	P5D
	inaq	Percentage Of Premium Outstanding Balance PercentageOfPremiumOutstandingBalance	0.20	pure
	inaq	Percentage Of Outstanding Balances Of Purchase Price PercentageOfOutstandingBalancesOfPurchasePrice	0.01	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.01	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.01	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.01	pure
	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.90	pure
	inaq	Number Of Trading Days NumberOfTradingDays	P5D
CY2024Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	100000	shares
CY2024Q3	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	426135	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Cash Cash		usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
	inaq	Change In Initial Value Of Forward Purchase Agreement Liability ChangeInInitialValueOfForwardPurchaseAgreementLiability		usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2024Q3	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
CY2023Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
	inaq	Gain On Forgiveness Of Deferred Underwriting Fee Payable GainOnForgivenessOfDeferredUnderwritingFeePayable		usd
	inaq	Gain Loss Change In Fair Value Of Forward Purchase Agreement Liability GainLossChangeInFairValueOfForwardPurchaseAgreementLiability		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	inaq	Increase Decrease Due From Sponsor IncreaseDecreaseDueFromSponsor		usd
	inaq	Increase Decreasein Due To Investors IncreaseDecreaseinDueToInvestors		usd
	inaq	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable		usd
	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates		usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	inaq	Proceeds Pursuant To Subscription Agreement ProceedsPursuantToSubscriptionAgreement		usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash		usd
	inaq	Forgiveness Of Deferred Underwriting Fee Payable ForgivenessOfDeferredUnderwritingFeePayable		usd
	inaq	Fair Value Of Subscription Shares FairValueOfSubscriptionShares		usd
	inaq	Increase In Due To Investor IncreaseInDueToInvestor		usd
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue		usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue		usd
CY2024Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001862463

Files In Submission

Name	View Source	Status
0001213900-24-099383-index-headers.html	Edgar Link	pending
0001213900-24-099383-index.html	Edgar Link	pending
0001213900-24-099383.txt	Edgar Link	pending
0001213900-24-099383-xbrl.zip	Edgar Link	pending
ea0221240-10q_insight.htm	Edgar Link	pending
ea022124001ex10-15_insight.htm	Edgar Link	pending
ea022124001ex2-3_insight.htm	Edgar Link	pending
ea022124001ex31-1_insight.htm	Edgar Link	pending
ea022124001ex31-2_insight.htm	Edgar Link	pending
ea022124001ex32-1_insight.htm	Edgar Link	pending
ea022124001ex32-2_insight.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
inaq-20240930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
inaq-20240930_cal.xml	Edgar Link	unprocessable
inaq-20240930_def.xml	Edgar Link	unprocessable
inaq-20240930_lab.xml	Edgar Link	unprocessable
ea0221240-10q_insight_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
inaq-20240930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMOD
ALPHA MODUS HOLDINGS, INC. Stock $amod

2024 Q3 Form 10-Q Financial Statement

#000121390024099383 Filed on November 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMOD ALPHA MODUS HOLDINGS, INC. Stock $amod

2024 Q3 Form 10-Q Financial Statement

#000121390024099383 Filed on November 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMOD
ALPHA MODUS HOLDINGS, INC. Stock $amod